Why The Application Research of Shensong Yangxin Capsule won the first prize?
1. Theoretical innovation: Featured by simultaneously treating tachyarrhythmia and bradycardia, open up a new way to treat arrhythmia from "rhythm control" to "rhythm regulation".
2. Definite effect: Firstly carried out the prospective, randomized, double-blind, multicenter evidence-based study in China, result proved that Shensong Yangxin Capsule can effectively treat premature beats, atrial fibrillation and bradyarrhythmia, offering an exact treatment option for refractory diseases such as ventricular premature beats with heart failure and sinus bradycardia with ventricular premature beats.
3. High safety: Compared with antiarrhythmic conventional medicine, Shensong Yangxin Capsule has obvious safety advantages without arrhythmogenic side effects.
4. Unique mechanism: According to experimental studies, as Shensong Yangxin Capsules can blockade ion channels and regulate non-ion channels, it can effectively treat arrhythmia by improving microcirculation, reversing cardiac remodeling, electrical remodeling and neural remodeling.
